Early in the beginning of the COVID-19 pandemic, scientists predicted the coronavirus would mutate slowly. They were wrong. Hundreds of thousands of viral mutations and multiple seasonal waves later, ...

Scientists have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV-2: their ability to mutate and evade ...

Researchers have developed EVE-Vax, an AI tool that forecasts viral mutations and designs test proteins to guide next-generation vaccines. The breakthrough could allow scientists to build vaccines ...

Researchers have developed EVE-Vax, a computational design tool that creates synthetic SARS-CoV-2 spike proteins mimicking future immune-evading variants. These designed proteins enable early ...

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have created the most comprehensive map to date showing how antibodies attach to the SARS-CoV-2 virus, which causes ...

This month’s story comes from the Bloom lab using their signature deep mutational scanning technique to identify mutations in the surface protein of Lassa virus -called glycoprotein- that escape ...

Many viruses, particularly RNA viruses, mutate at a very high rate per genome per replication. One possible explanation is that high mutation rates are selected to meet the challenge of fluctuating ...

New computational modeling of avian influenza variants' immunoprotein interactions—developed by a research team at the University of North Carolina at Charlotte—reveals the H5N1 influenza virus is ...